A PHASE I TRIAL OF AN IMMUNE CHECKPOINT INHIBITOR PLUS STEREOTACTIC ABLATIVE RADIOTHERAPY IN PATIENTS WITH INOPERABLE STAGE I NON-SMALL CELL LUNG CAN
$527,936FY2015Department of the ArmyDOD
University Of California, Davis
University Of California, Davis